Recent News
New Data Shows Patients Living with a Heart Pump Benefit from Following an Aspirin-Free Regimen
<p>For the first time, new data shows that an aspirin-free regimen can improve outcomes for people living with a heart pump by reducing hospitalizations without increasing the risk of blood clots, according to the ARIES-HM3 study. The trial was the first international, placebo-controlled randomized study to assess whether the absence of aspirin is safe and decreases bleeding in people with a left ventricular assist device, known as an LVAD, or heart pump, to treat advanced heart failure.</p>
New Strategy Attacks Treatment-Resistant Lymphomas
A surprising mechanism that makes some cancers treatment-resistant has been discovered by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Mobile Stroke Units Increase Odds of Averting Stroke
Receiving a clot-busting drug in an ambulance-based mobile stroke unit (MSU) increases the likelihood of averting strokes and complete recovery compared with standard hospital emergency care.
Dr. Maya Hogg Named Chief of Medicine at NewYork-Presbyterian Lower Manhattan Hospital
Dr. Maya Hogg, a leading hospitalist, has been appointed chief of medicine at NewYork-Presbyterian Lower Manhattan Hospital and vice chair in the Weill Department of Medicine at Weill Cornell Medicine, effective Oct. 1.
Combination Radiation with Immunotherapy Shows Promise Against “Cold” Breast Cancer Tumors
Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy—one that boosts T cells, and another that boosts dendritic cells—can control tumors in preclinical models of triple negative breast cancer, a cancer type that’s typically resistant to immunotherapy alone.
Featured Stories
Health Matters 7 Min Read